relaxation phases. He was given plentiful fluids and nutritious food and sedated with haloperidol 5 mg eight hourly. Within 48 hours his mental state was much improved and regular sedation was stopped. In view of the hypertensive heart disease thyroxine replacement was started cautiously-25 ,g on alternate days, increasing weekly by 25 mg on alternate days to 50 mg daily. Transaminase activities became normal within a week, but renal impairment persisted (see  table) .
The patient spent one month in hospital, during which his mental state settled gradually and was normal by the time of discharge without psychoactive drugs.
Comment
This case fits the criteria for mania listed by the Diagnostic and Statistical Manual of Mental Disorders (3rd edition) and the ninth revision of the International Classification of Diseases. The association of mania and myxoedema must be very rare, and we can find no other reported case. 1-5 The two usual psychiatric syndromes seen in myxoedema are, firstly, confusion and cognitive impairment resembling dementia, sometimes with clouding of consciousness; and, secondly, depressed mood with paranoid delusional ideas and often hallucinations.' 2 Irritability and violence are reported only in association with paranoid cases. 2 Our patient showed no psychiatric disorder until further metabolic disturbance was superimposed on his thyroid deficiency. After surgery he had a mental disturbance which may have been mild hypomania, which suggests that he may have been particularly susceptible to develop a mental disturbance from metabolic abnormality as an expression of his genetic predisposition indicated by the positive family history.
We thank Professor J T Silverstone for his help and advice in preparing this report. 
Faecal peritonitis induced by Picolax
We report a case of faecal peritonitis after the use of Picolax (sodium picosulphate) before barium enema examination. The cause was a perforated diverticulum of the sigmoid colon 10 cm proximal to an obstructive rectosigmoid carcinoma. We beIieve that this is the first report of faecal peritonitis after the administration of Picolax.
Case report -A 73 year old man was admitted to hospital complaining of abdominal pain of sudden onset that had become worse in the hour before admission. On examination the abdomen was distended, silent, and rigid. Blood pressure was 100/80 mm Hg and the pulse rate 120/min. An erect chest radiograph showed gas under both diaphragms. At laparotomy liquid faeces were found in the peritoneal cavity and the sigmoid colon proximal to an obstructing carcinoma of the rectosigmoid junction was perforated. There was moderate diverticular disease of the descending colon above the perforation. Hartmann's procedure and peritoneal lavage were performed. Histological examination of the resected specimen showed a moderately differentiated adenocarcinoma of the sigmoid colon and a perforated diverticulum 10 cm proximal to the carcinoma; there was spread to the lymph nodes. The intervening colon was reported as being normal. Postoperatively the patient developed septicaemic shock and renal failure, which failed to respond to treatment. He died three weeks later.
One month before admission the patient had attended the outpatient department complaining of diarrhoea and abdominal pain. He did not give a history of passing blood, and a rigid sigmoidoscopy to 15 cm did not show any abnormalities. A barium examination of the colon was planned for the day on which he was admitted. During the evening before admission he had taken two sachets of Picolax in preparation for the barium enema.
Comment Carcinoma and diverticular disease are common disorders of the colon. Their diagnosis often depends on a barium enema or colonoscopic examination, which in turn depend on good preparation of the bowel. Picolax is a stimulant laxative containing sodium picosulphate and magnesium citrate that has been used for both barium and colonoscopic examinations with good results.' 2 The perforation in this case was due to diverticular disease and was precipitated by Picolax and the distal obstructing carcinoma. Rose et al stated that Picolax should be used with caution in patients with potentially obstructive lesions or diarrhoea,2 and we endorse this view. We would add that any patient suffering from diarrhoea or abdominal pain in whom a carcinoma is suspected should undergo flexible sigmoidoscopy before being given Picolax. If there are clinical signs of obstruction Picolax should not be used. In cases in which the bowel appears normal on flexible sigmoidoscopy we believe that Picolax should be given under medical supervision-that is, while they are in hospital for the ensuing examination.
We emphasise that Picolax is a safe and efficient means of colonic preparation. For its safe record to be maintained patients at risk must be preselected for careful assessment before it is used.
We are grateful to Dr J Burston for the histological examination and to Anne Reavley for secretarial help. 
Incidence of the premenstrual syndrome in twins
The premenstrual syndrome is a recognised clinical entity with both psychiatric and physical symptoms,' but its cause remains in dispute.2 This study was instituted to determine whether a genetic factor is concerned.
Subjects, methods, and results
The premenstrual syndrome is defined as the recurrence of symptoms limited to the premenstruum with complete absence of symptoms for at least seven consecutive days in the postmenstruum.2 Subjects were drawn from a premenstrual syndrome clinic run by KD, and all 108 index patients had completed a three month prospective menstrual chart that had resulted in a positive diagnosis of the premenstrual syndrome. There were 15 pairs of monozygous twins and 16 pairs of dizygous female/female twins; their zygosity was determined from their medical records after the diagnosis of the premenstrual syndrome had been confirmed. Controls with confirmed premenstrual syndrome and at least one sister were enlisted between May and October 1986. Siblings were regarded as suffering from the syndrome if they had received treatment for it and it had been confirmed by a menstrual chart. The female siblings of 68 (52%) of the subjects were interviewed, information on the remaining siblings being obtained from the subjects' personal knowledge or from correspondence. No twins or control siblings had been reared separately. Any previous medical and psychiatric illnesses, in index subjects and in male and female siblings were also recorded. The data were analysed by the X2 test.
Among the 15 sets of monozygous twins bothtwin siblings suffered from the premenstrual syndrome in every case except one, whereas in the group of dizygous twins only seven of the 16 twin siblings suffered. The 77 controls had 121 female siblings, ofwhom 38 suffered from the syndrome. This gives a p value of <0-001 for monozygous twins versus controls but no significant difference between dizygous twins and controls. The incidence of previous medical or psychiatric illness among twins, controls, and their siblings was similar.
Comment
Twin studies are a useful method of illustrating "horizontally" the genetic element of disease.3 In the one monozygous twin pair in which only the index patient had the premenstrual syndrome she had started to suffer from it after the birth of the first of her two children, whereas her sibling was nulliparous.
Dalton reported that the premenstrual syndrome started after pregnancy in two fifths of 769 women,2 so will this monozygous twin sister remain free from it after she has borne children?
Kantero and Widholm found a highly significant correlation for premenstrual symptoms (as opposed to the premenstrual syndrome) in Finnish adolescent daughters and their natural mothers.4 This further supports the suggestion that there is a genetic element in the aetiology of the premenstrual syndrome.
Our findings contribute to the theory that the study of nature, not nurture, holds the key to the aetiology of the premenstrual syndrome. Thus probably inquiries into antenatal factors and childhood environment are unfruitful topics for research into its aetiology and resources would be better employed investigating endocrinological factors. 
Continuous arteriovenous haemofiltration in patients with hepatic encephalopathy and renal failure
The mortality of patients admitted with fulminant hepatic failure remains high.
I Charcoal haemoperfusion and dialysis with a polyacrylonitrile membrane have both been reported to increase survival.2 Though death is often due to multiple complications, cerebral oedema is a common and serious problem.3 Treatments designed to control raised intracranial pressure are not always successful; hyperventilation does not produce a sustained reduction in pressure, and mannitol, which can control raised intracranial pressure, is not as effective in patients who have renal failure or appreciably increased pressures. 4 We treated a patient who had hepatorenal failure by two methods of haemofiltration, with different effects on intracranial pressure.
Case report
A previously healthy 25 year old woman took 100 paracetamol tablets (0-5 g each) pending a divorce settlement. Three days later she started to feel unwell, became confused, and was admitted to the regional liver unit with grade IV hepatic encephalopathy. On arrival she responded only to deep pain and showed icterus with anuria. It has been suggested that haemofiltration, by minimising systemic osmotic gradients, would be a better approach than haemodialysis and would diminish both the incidence and severity of cerebral oedema. In this case continuous arteriovenous haemofiltration, with an ultrafiltration rate of 1000 ml/hour, caused less change in intracranial pressure than machine driven haemofiltration, with a 17 litre exchange of fluid in three to four hours. Continuous arteriovenous haemofiltration may therefore have an advantage in the treatment of patients who have hepatic encephalopathy complicated by acute renal failure.
